Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: United Kingdom Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20053
20063
20071
20094
20104
20114
20123
20131
20155
20164
20175
20182
20199
20207
20219
20225
20234
20249
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Unknown status14
Terminated13
Active, not recruiting12
Recruiting11
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Marsden NHS Foundation Trust9
Seagen Inc.6
AstraZeneca4
Imperial College London4
Seagen, a wholly owned subsidiary of Pfizer4
Cancer Research UK3
European Organisation for Research and Treatment of Cancer - EORTC3
GlaxoSmithKline3
Institute of Cancer Research, United Kingdom3
Merck Sharp & Dohme LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms91
Ovarian Neoplasms32
Endometrial Neoplasms30
Carcinoma, Non-Small-Cell Lung19
Urinary Bladder Neoplasms16
Stomach Neoplasms15
Esophageal Neoplasms14
Squamous Cell Carcinoma of Head and Neck13
Breast Neoplasms12
Neoplasms12

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.